彪马

最新新闻

• TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2025/11/8
• 评级变动
  HC Wainwright & Co. : The Puma Biotechnology (PBYI.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.
  Zhitong Finance · 2024/5/20
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI)
  TipRanks · 2023/2/1
• Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ...
  Yahoo Finance · 2025/11/7
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI)
  TipRanks · 2023/6/5
• 评级变动
  TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2025/8/8
• Earnings Call Summary | Puma Biotechnology(PBYI.US) Q4 2025 Earnings Conference
  \u5e02\u573a\u8d44\u8baf · 2026/2/27
• 评级变动
  TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Raises Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2025/11/7
• Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
  Yahoo Finance · 2026/2/27
• 评级变动
  H.C. Wainwright Sticks to Its Buy Rating for Puma Biotechnology (PBYI)
  TipRanks · 2022/12/9
• Barclays Maintains Puma Biotechnology(PBYI.US) With Sell Rating, Maintains Target Price $2
  \u5e02\u573a\u8d44\u8baf · 2025/11/7
• 评级变动
  H.C. Wainwright Maintains Puma Biotechnology(PBYI.US) With Buy Rating, Maintains Target Price $7
  \u5e02\u573a\u8d44\u8baf · 2025/2/28

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。